High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away
It is the most significant merger in the European cannabis sector. SynBiotic SE has acquired 50.1% of Daniel Kruse’s group
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards
CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off
AFTER recently announcing billionaire investor Christian Angermayer had become its largest shareholder German cannabis company SynBiotic has secured a further
LOVE Hemp Group informed its investors this week that its upcoming admission to the London Stock Exchange’s (LSE) is “imminent”.
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.